For the Inventor, By the Inventor

Enter assignee name

Newtown, PA, United States of America

Onconova Therapeutics, Inc.

USPTO Granted Patents = 19

CIPO Patents = 34

EPO Patents = 18

Forward Citations = 46

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Stanley Charles Bell (13 out of 55 patents)

M V Ramana Reddy (9 out of 45 patents)

Manoj Maniar (8 out of 12 patents)

4. E Premkumar Reddy (5 out of 45 patents)

5. Azra Raza (1 out of 2 patents)

6. Francois Wilhelm (1 out of 1 patent)

7. Ramesh Kumar (1 out of 10 patents)

8. Glenn J Fegley (1 out of 3 patents)

9. Stephen Cosenza (1 out of 4 patents)

10. Jodie Duke (1 out of 2 patents)

11. Reddy E Premkumar (1 out of 1 patent)

12. Reddy M V Ramana (1 out of 1 patent)

13. Albert Wong (1 out of 1 patent)

14. Mv Ramana Reddy (1 out of 3 patents)

15. Lawrence Helson (22 patents)

19 patents: Sort by Forward Citations

1. 11382877 - Formulation of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability (2022-07-12),

2. 10576050 - Methods and compositions for treatment of cancer (2020-03-03),

3. 10098862 - Formulations with enhanced stability and bioavailability for administration of (E)-2,6-dialkoxystyryl 4-substituted benzylsulfones (2018-10-16),

4. 9713597 - Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone (2017-07-25),

5. 9060967 - Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone (2015-06-23),

6. 9044427 - Compositions and methods for prevention and treatment of wounds (2015-06-02),

7. 8476320 - Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfones (2013-07-02),

8. 8324190 - Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones (2012-12-04),

9. 8273787 - Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions (2012-09-25),

10. 8143453 - Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis (2012-03-27),

11. 8063109 - Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones (2011-11-22),

12. 7932242 - Substituted phenoxy-and phenylthio-derivatives for treating proliferative disorders (2011-04-26),

13. 7598232 - [object Object] (2009-10-06),

14. 7161031 - Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders (2007-01-09),

15. 7094903 - Processes for the preparation of substituted isoxazoles and 2-isoxazolines (2006-08-22),

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. The company is dedicated to transforming the lives of cancer patients by targeting key signaling pathways involved in the progression of various types of cancer. Onconova's innovative approach aims to improve the efficacy and safety of cancer treatments and ultimately provide new options for patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

19 Patents

#3 in Newtown, PA

#618 in Pennsylvania

#16,575 in US

#31,645 in the World

Newtown, PA, United States of America

Onconova Therapeutics, Inc.

Forward Citations = 46

29 inventors:

Stanley Charles Bell (13 out of 55 patents)

M V Ramana Reddy (9 out of 45 patents)

Manoj Maniar (8 out of 12 patents)

4. E Premkumar Reddy (5 out of 45 patents)

5. Azra Raza (1 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…